✦ LIBER ✦

433 5-Fluorouracil blocks lymphocyte activity during immunochemotherapy with interferon-alpha, interleukin-2 and 5-fluorouracil in metastatic renal cell carcinoma: An in vitro and ex vivo analysis

✍ Scribed by M. Siebels; K. Rohrmann; H. Pohla; A. Hofstetter

Book ID: 118645643
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 217 KB
Volume: 3
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(04)90430-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5- fluorouracil blocks T-cell activity d

5- fluorouracil blocks T-cell activity during immunochemotherapy in combination with interferon-alpha and interleukin-2 in metastatic renal cell carcinoma

✍ K. Rohrmann; R. Oberneder; H. Pohla; A. Hofstetter; M. Siebels 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Interleukin-2 with interferon- α 2a and

Interleukin-2 with interferon- α 2a and 5-fluorouracil improves objective response rate compared with tamoxifen in people with metastatic renal cell carcinoma

✍ A. Ravaud 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 93 KB

A Phase II trial of intravenous gemcitab

A Phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-α in patients with metastatic renal cell carcinoma

✍ Christopher W. Ryan; Nicholas J. Vogelzang; Walter M. Stadler 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract ## BACKGROUND The objective of this study was to determine the response rate and toxicity of gemcitabine and continuous‐infusion 5‐fluorouracil (5‐FU) in combination with subcutaneous interleukin‐2 (IL2) and interferon‐α (IFNA) in patients with metastatic renal cell carcinoma. ## METH

150 - Subcutaneous (SC) interleukin-2 (I

150 - Subcutaneous (SC) interleukin-2 (IL-2) plus alpha interferon (IFN-α) and 5 fluorouracil (5 FU) in out-patients (pts) with metastatic renal cell carcinoma (MRCC). Scapp II trial

✍ J.M. Tourani; A. Benhammouda; P. Guillet; C. Pfister; B. Paule; J.F. Berbah; Y. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Protracted venous infusion 5-fluorouraci

Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II study.

✍ MJ Allen; M Vaughan; A Webb; S Johnston; P Savage; T Eisen; S Bates; J Morre; R 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Subcutaneous interleukin-2, interferon a

Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial

✍ Ravaud, A; Trufflandier, N; Ferrière, J M; Debled, M; Palussière, J; Cany, L; Ga 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB